Trans patients are already losing access to gender-affirming healthcare while the federal government intensifies pressure on the hospitals and clinicians providing it. In Massachusetts, where state officials say gender-affirming care for minors remains legal and covered, providers including Fenway Health, Baystate Health, and Outer Cape Health Services have halted or restricted care for patients 18 and younger amid federal pressure. The legal right to treatment has not guaranteed that a doctor will still be there to provide it.
That is the human reality beneath Donald Trump’s latest boast. Speaking at an Aug. 21 rally in Myrtle Beach, South Carolina, Trump claimed hospitals were performing what he called “reverse surgery” on trans people “at my order.” There is no recognized medical procedure called “reverse surgery.” What does exist is a federal campaign using money, investigations, settlements, subpoenas, and administrative power to force gender-affirming care out of hospitals and away from trans patients.
The pressure is already reaching federal healthcare funding. On Aug. 11, the Department of Health and Human Services and the Centers for Medicare & Medicaid Services finalized a rule cutting federal Medicaid funding for specified gender-affirming procedures for patients under 18 and CHIP funding for patients under 19. The administration set an October implementation date, with limited transition provisions for some patients already receiving hormone treatment. For trans youth and families who depend on those programs, federal financing is being turned into leverage over whether treatment remains available at all.
The Justice Department has been applying pressure directly to hospitals as well. Texas Children’s Hospital agreed to end specified gender-affirming care for minors. Cleveland Clinic entered a long-term agreement ending puberty blockers and hormone treatment for minors. Connecticut Children’s agreed to stop providing puberty blockers, hormones, and surgeries to minors and pay a financial penalty. These are not theoretical policy debates. They are hospitals removing services from trans patients after the federal government brought its enforcement power to their doors.
That distinction matters because healthcare can disappear without Congress passing a single nationwide ban. A state can continue to protect gender-affirming care while federal agencies expose hospitals to funding losses, investigations, record demands, penalties, and prolonged legal pressure. Patients experience the result before the legal architecture is ever settled: appointments disappear, programs close, and continuity of care becomes less certain.
Massachusetts makes that contradiction especially clear. State officials continue to say gender-affirming care remains lawful and covered, yet multiple providers have already pulled back. For trans patients, the practical question is not whether a statute still recognizes their right to treatment. It is whether a clinic will still accept them, whether a provider will continue prescribing their medication, and whether federal pressure will make another institution decide that treating them carries too much risk.
The administration is attacking providers from several directions at once. HHS has scrutinized insurance coding and financial practices associated with gender-affirming care for minors. DOJ has pursued hospital agreements and investigations. Federal authorities have sought medical records connected to trans patients. The cumulative pressure reaches beyond a single hospital policy because it makes the continued provision of care itself a potential source of legal, financial, and administrative exposure.
Medical privacy has become part of that attack. DOJ sought records connected to pediatric gender-affirming care from hospitals, while courts have pushed back against some of those demands. In California, a federal judge blocked efforts to obtain records involving trans minors from Stanford-affiliated Lucile Packard Children’s Hospital, placing patient privacy directly inside the legal fight over the administration’s campaign.
For trans patients and their families, that means the federal government is reaching not only toward the treatment room but toward the records documenting what happens inside it. A young person seeking lawful healthcare can now face a system in which the provider, the funding source, and the privacy of the medical file are all under federal pressure at the same time.
Trump’s Myrtle Beach statement lands differently against that record. His phrase “reverse surgery” is medically incoherent, but his declaration that the rollback is happening “at my order” sits beside an administration already cutting funding and pushing hospitals out of providing care. The boast matters because Trump is publicly claiming ownership of an outcome that trans patients are already experiencing: fewer providers willing or able to treat them.
The administration does not need to make every form of gender-affirming care illegal nationwide to produce that result. It can make treatment harder to provide, more expensive for institutions to defend, riskier for hospitals to maintain, and more vulnerable to federal scrutiny. A healthcare right that survives on paper can still become unreachable when the infrastructure needed to exercise it is dismantled around the patient.
That is where the harm becomes larger than any one regulation. Gender-affirming healthcare depends on continuity: clinicians who remain available, medications that can be prescribed without interruption, hospitals willing to provide treatment, insurance that will pay for it, and patients able to trust that seeking care will not place their medical records inside a federal enforcement campaign. When those pieces are attacked together, access can collapse even before the underlying right formally disappears.
Hospitals also have choices inside that pressure. Federal coercion is driving provider retreat even where gender-affirming care remains legal. The patients losing care are the ones carrying the consequences of those decisions. Every hospital that closes or narrows a program transfers the burden downward to trans youth and families who must determine whether another provider exists, whether treatment can continue, and whether care that was available yesterday will still exist tomorrow.
Trump’s statement therefore should not be treated as another bizarre line from a political rally. The important words were not “reverse surgery.” They were “at my order.” They connect presidential rhetoric to a federal apparatus already using funding, enforcement, settlements, investigations, and medical-record demands to force healthcare systems backward.
Trans patients are the ones living inside that rollback. They are losing providers while care remains legal, watching hospitals retreat under federal pressure, and facing a government increasingly willing to use healthcare financing and enforcement power against the systems that treat them.
Trump can call that “reverse surgery.” The record shows something more concrete: a federal government using its power to make trans healthcare disappear before the law formally erases it.
Trans patients are already losing access to care as federal pressure pushes hospitals and providers to retreat. What remains legal on paper is being made harder to reach in practice — leaving patients and families to absorb the disruption.
Trans United documents how federal power, institutional retreat, and anti-trans policy translate into lost healthcare, broken continuity of care, and direct harm to trans lives.
Upgrade to a paid subscription to support independent Trans United reporting and accountability work.
🖕🤡🖕